(Q48934243)

17 February 2018

title

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients. (English)

1 reference

17 February 2018

1 reference

1

1 reference

17 February 2018

Andrés Felipe Cardona

object named as

Andrés Felipe Cardona

4

0 references

Rafael Rosell

11

object named as

Rafael Rosell

1 reference

17 February 2018

Cristina Carrato

2

1 reference

17 February 2018

José Luis Ramírez

3

1 reference

17 February 2018

Mireia Berdiel

5

1 reference

17 February 2018

José Javier Sánchez

6

1 reference

17 February 2018

Miquel Tarón

7

1 reference

17 February 2018

Cristina Hostalot

8

1 reference

17 February 2018

Eva Musulen

9

1 reference

17 February 2018

Aurelio Ariza

10

1 reference

17 February 2018

publication date

1 September 2011

1 reference

17 February 2018

Clinical and Translational Oncology

published in

1 reference

17 February 2018

volume

13

1 reference

17 February 2018

issue

9

1 reference

17 February 2018

page(s)

677-685

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s12094-011-0714-x

exact match

0 references

cites work

Increased repair of O6-alkylguanine DNA adducts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Variability and regulation of O6-alkylguanine-DNA alkyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Detection of messenger RNA from O6-methylguanine-DNA methyltransferase gene MGMT in human normal and tumor tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Patterns of care for adults with newly diagnosed malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Clinical course of high-grade glioma patients with a "biopsy-only" surgical approach: a need for individualised treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Isolation and characterization of DNA from the plasma of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Methylated tumor-specific DNA as a plasma biomarker in patients with glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Methylguanine methyltransferase testing in glioblastoma: when and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

MGMT methylation status: the advent of stratified therapy in glioblastoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0714-X

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme

21 January 2018

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics.

1 reference

12 December 2020

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Expression of the O6-methylguanine-DNA methyltransferase gene MGMT in MER+ and MER- human tumor cells

1 reference

12 December 2020

MGMT immunohistochemical expression and promoter methylation in human glioblastoma

1 reference

12 December 2020

A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue.

1 reference

12 December 2020

Neurosurgeons achieve world's first delivery of intra-arterial bevacizumab directly into brain tumor of glioblastoma multiforme patients

1 reference

12 December 2020

The origin and mechanism of circulating DNA

1 reference

12 December 2020

Re: Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer

1 reference

12 December 2020

Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells

1 reference

12 December 2020

Free DNA in the serum of cancer patients and the effect of therapy.

1 reference

12 December 2020

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

1 reference

12 December 2020

Pharmacology of cyclophosphamide and metabolites.

1 reference

12 December 2020

10.1007/S12094-011-0714-X

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

21865140

1 reference

17 February 2018